透明带基因变异与女性不孕症的关联:一项回顾性遗传学分析
本研究回顾性分析12例控制性促排卵后仅获空卵泡或退化卵母细胞且辅助生殖技术治疗后未获成功妊娠的患者,采用二代测序和Sanger测序检测透明带基因变异,共鉴定14个变异(含8个新变异),涉及ZP1、ZP2和ZP3杂合变异。作者认为透明带基因变异与女性不孕症相关,可能影响辅助生殖技术结局,建议对具有相关临床和实验室指标且辅助生殖技术失败的患者进行透明带基因变异筛查,但需进一步研究确认这些变异的功能影响。
要点
- 12例控制性促排卵后仅获空卵泡或退化卵母细胞且辅助生殖技术未获成功妊娠的患者中鉴定出14个透明带基因变异,含8个新变异。
- 变异包括ZP1、ZP2和ZP3的杂合变异。
- 作者建议对辅助生殖技术失败且具有相关临床和实验室指标的女性患者进行透明带基因变异筛查。
核心结论
- 透明带基因变异与女性不孕症相关,可能影响辅助生殖技术结局。
- 作者建议对辅助生殖技术失败且具有相关临床和实验室指标的女性患者进行透明带基因变异筛查,以指导个体化治疗并改善生育结局。
- 作者指出需进一步研究确认这些变异的功能影响。
研究设计与样本
- 回顾性研究,设置于大学附属生殖医学中心。
- 研究对象为12例控制性促排卵后仅获空卵泡或退化卵母细胞且辅助生殖技术治疗后未获成功妊娠的患者。
- 方法为对患者外周血DNA进行二代测序和Sanger测序,使用SnpEff参照refSeq、gnomAD、dbSNP、InhouseSNP、ClinVar和dbNSFP数据库对Genome Analysis Toolkit生成的VCF文件进行功能注释,并使用InterVar对SnpEff结果进行美国医学遗传学与基因组学学会(ACMG)注释。
主要发现
- 共鉴定14个透明带基因变异,包括8个新变异。
- 变异包括ZP1、ZP2和ZP3的杂合变异。
临床怎么用
- 作者建议对辅助生殖技术失败且具有相关临床和实验室指标的女性患者进行透明带基因变异筛查,以指导个体化治疗并改善生育结局。
局限性
- 作者指出需进一步研究确认这些变异的功能影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We investigated the clinical characteristics and pregnancy outcomes of patients with zona pellucida (ZP) gene variants undergoing assisted reproductive technology (ART) treatment, to identify variants associated with female infertility. DESIGN: Retrospective study. SETTING: University-based reproductive medicine centre. POPULATION: Twelve patients in whom only empty follicles or degenerated oocytes were retrieved after controlled ovulation stimulation and for whom no successful pregnancies were achieved after ART treatment. METHODS: Next-generation sequencing (NGS) and Sanger sequencing were performed on DNA obtained from peripheral blood of the patients. The VCF files generated by the Genome Analysis Toolkit were functionally annotated using SnpEff with reference to the refSeq, gnomAD, dbSNP, InhouseSNP, ClinVar and dbNSFP databases. MAIN OUTCOME MEASURES: American College of Medical Genetics and Genomics (ACMG) annotation of the SnpEff results was performed using InterVar. RESULTS: We identified 14 ZP variants, including eight novel variants. These included heterozygous variants in ZP1, ZP2 and ZP3. These findings contribute to the understanding of ZP gene variants and their roles in the diagnosis of an abnormal ZP. CONCLUSIONS: ZP gene variants are associated with female infertility, which can potentially affect ART outcomes. Therefore, ZP gene variant screening should be performed in female patients experiencing ART failure with pertinent clinical and laboratory indicators to guide personalised treatment and enhance fertility outcomes. However, further research is required to confirm the functional impact of these variants.
引用
- Sa SW, Wang LL, Ma QH, et al. Association of Zona Pellucida Gene Variants With Female Infertility: A Retrospective Genetic Analysis. BJOG. 2025. PMID: 39932488. doi:10.1111/1471-0528.18094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。